Inventor · disambiguated record
Michael C. Jensen
Also filed as: JENSEN MICHAEL · JENSEN MICHAEL C · JENSEN MICHAEL CHRIS
69 granted patents·57 pending applications·3,988 citations·filing 1998–2025
99Inventor score
Files withSEATTLE CHILDRENS HOSPITAL31HOPE CITY23SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST21UNIV CALIFORNIA7HUTCHINSON FRED CANCER RES6
Top patents by PatentIndex Score
126 records- 0198US11123369B2Bispecific CAR T-cells for solid tumor targetingSEATTLE CHILDRENS HOSPITAL·Filed 2020·Granted Sep 21, 2021·8 cites·16 claims
- 0297US11639387B2Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereof to treat diseaseSEATTLE CHILDRENS HOSPITAL·Filed 2020·Granted May 2, 2023·8 cites·17 claims
- 0397US10865242B2Method and compositions for cellular immunotherapySEATTLE CHILDRENS HOSPITAL·Filed 2015·Granted Dec 15, 2020·11 cites·17 claims
- 0497US10829556B2Polynucleotides encoding bispecific chimeric antigen receptorsSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted Nov 10, 2020·14 cites·22 claims
- 0597US10736918B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2017·Granted Aug 11, 2020·24 cites·30 claims
- 0697US10266592B2Drug regulated transgene expressionSEATTLE CHILDRENS HOSPITAL·Filed 2015·Granted Apr 23, 2019·19 cites·25 claims
- 0797US10189903B2Bispecific chimeric antigen receptors and methods of use thereof to treat cancerSEATTLE CHILDRENS HOSPITAL·Filed 2016·Granted Jan 29, 2019·26 cites·87 claims
- 0897US9447194B2Bispecific chimeric antigen receptors and encoding polynucleotides thereofSEATTLE CHILDREN'S HOSPITAL·Filed 2013·Granted Sep 20, 2016·111 cites·28 claims
- 0997US8822647B2Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cellsJENSEN MICHAEL·Filed 2009·Granted Sep 2, 2014·314 cites·7 claims
- 1097US8802374B2Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selectionJENSEN MICHAEL C·Filed 2012·Granted Aug 12, 2014·286 cites·20 claims
- 1197US8497118B2Chimeric immunoreceptor useful in treating human cancersJENSEN MICHAEL·Filed 2012·Granted Jul 30, 2013·67 cites·4 claims
- 1297US8324353B2Chimeric immunoreceptor useful in treating human gliomasJENSEN MICHAEL·Filed 2011·Granted Dec 4, 2012·312 cites·5 claims
- 1397US7514537B2Chimeric immunoreceptor useful in treating human gliomasHOPE CITY·Filed 2005·Granted Apr 7, 2009·230 cites·4 claims
- 1497US7446191B2DNA construct encoding CE7-specific chimeric T cell receptorHOPE CITY·Filed 2008·Granted Nov 4, 2008·450 cites·2 claims
- 1597US7354762B2Method for producing CE7-specific redirected immune cellsHOPE CITY·Filed 2007·Granted Apr 8, 2008·312 cites·1 claims
- 1697US7265209B2CE7-specific chimeric T cell receptorHOPE CITY·Filed 2006·Granted Sep 4, 2007·397 cites·1 claims
- 1797US7070995B2CE7-specific redirected immune cellsHOPE CITY·Filed 2002·Granted Jul 4, 2006·486 cites·4 claims
- 1897US6410319B1CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignanciesHOPE CITY·Filed 1999·Granted Jun 25, 2002·719 cites·22 claims
- 1996US11458167B2Bispecific CAR T-cells for solid tumor targetingSEATTLE CHILDRENS HOSPITAL·Filed 2016·Granted Oct 4, 2022·12 cites·14 claims
- 2096US11155616B2Drug regulated transgene expressionSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted Oct 26, 2021·6 cites·19 claims
- 2196US10780118B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2013·Granted Sep 22, 2020·21 cites·37 claims
- 2295US12269862B2Methods of use for CAR T cellsPURDUE RESEARCH FOUNDATION·Filed 2023·Granted Apr 8, 2025·2 cites·15 claims
- 2395US12091459B2Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancerSEATTLE CHILDRENS HOSPITAL·Filed 2023·Granted Sep 17, 2024·2 cites·30 claims
- 2495US11311576B2Methods of use for CAR T cellsSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted Apr 26, 2022·10 cites·23 claims
- 2595US11160833B2Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20UNIV CALIFORNIA·Filed 2020·Granted Nov 2, 2021·7 cites·10 claims
- 2695US10869889B2Method and compositions for cellular immunotherapyHUTCHINSON FRED CANCER RES·Filed 2019·Granted Dec 22, 2020·8 cites·18 claims
- 2795US10611837B2Transgene genetic tags and methods of useSEATTLE CHILDRENS HOSPITAL·Filed 2015·Granted Apr 7, 2020·9 cites·13 claims
- 2894US12053491B2Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20UNIV CALIFORNIA·Filed 2023·Granted Aug 6, 2024·2 cites·9 claims
- 2993US11779602B2Methods of use for CAR T cellsENDOCYTE INC·Filed 2019·Granted Oct 10, 2023·7 cites·44 claims
- 3093US9580685B2Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selectionHOPE CITY·Filed 2014·Granted Feb 28, 2017·16 cites·23 claims
- 3192US11414486B2Transgene genetic tags and methods of useSEATTLE CHILDRENS HOSPITAL·Filed 2020·Granted Aug 16, 2022·2 cites·20 claims
- 3292US11155783B2Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selectionHOPE CITY·Filed 2018·Granted Oct 26, 2021·3 cites·20 claims
- 3391US12466885B2Bispecific chimeric antigen receptors and encoding polynucleotides, vectors and cells thereofSEATTLE CHILDRENS HOSPITAL·Filed 2024·Granted Nov 11, 2025·0 cites·30 claims
- 3491US11253546B2Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20UNIV CALIFORNIA·Filed 2015·Granted Feb 22, 2022·5 cites·11 claims
- 3591US10100281B2Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selectionHOPE CITY·Filed 2017·Granted Oct 16, 2018·7 cites·13 claims
- 3690US9217025B2Chimeric immunoreceptor useful in treating human cancersHOPE CITY·Filed 2013·Granted Dec 22, 2015·6 cites·8 claims
- 3788US12233090B2Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19UNIV CALIFORNIA·Filed 2024·Granted Feb 25, 2025·0 cites·18 claims
- 3888US12226435B2Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19UNIV CALIFORNIA·Filed 2024·Granted Feb 18, 2025·0 cites·21 claims
- 3988US10525082B2Genetic engineering of macrophages for immunotherapySEATTLE CHILDRENS HOSPITAL·Filed 2016·Granted Jan 7, 2020·14 cites·11 claims
- 4086US11649288B2Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agentsSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted May 16, 2023·2 cites·20 claims
- 4186US11278594B2Chimeric immunoreceptor useful in treating human cancersHOPE CITY·Filed 2019·Granted Mar 22, 2022·2 cites·8 claims
- 4286US10907175B2Isolated human cell with an inactivated glucocorticoid receptor geneSANGAMO BIOSCIENCES INC·Filed 2015·Granted Feb 2, 2021·2 cites·7 claims
- 4385US2024390491A1Method and compositions for cellular immunotherapyFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 4484US12448445B2Transgene genetic tags and methods of useSEATTLE CHILDRENS HOSPITAL·Filed 2022·Granted Oct 21, 2025·0 cites·17 claims
- 4583US12503507B2Defined composition gene modified T-cell productsSEATTLE CHILDRENS HOSPITAL·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 4683US11408005B2Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cellsSEATTLE CHILDRENS HOSPITAL·Filed 2017·Granted Aug 9, 2022·3 cites·20 claims
- 4783US10919950B2Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironmentSEATTLE CHILDRENS HOSPITAL·Filed 2017·Granted Feb 16, 2021·2 cites·19 claims
- 4883US10400215B2Adoptive transfer of CD8+ T cell clones derived from central memory cellsHOPE CITY·Filed 2014·Granted Sep 3, 2019·3 cites·16 claims
- 4982US12202897B2Drug regulated transgene expressionSEATTLE CHILDRENS HOSPITAL·Filed 2021·Granted Jan 21, 2025·0 cites·23 claims
- 5082US12098208B2Early intervention methods to prevent or ameliorate toxicitySEATTLE CHILDRENS HOSPITAL·Filed 2023·Granted Sep 24, 2024·0 cites·20 claims
Showing the top 50 of 126 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael C. Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →